Blue Crest Capital Management LTD Becton Dickinson & CO Transaction History

Blue Crest Capital Management LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $1.82 Million - $2.06 Million	7,928 New	7,928 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $27,045 - $140,041	530 Added 7.63%	7,479 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $5.11 Million - $6 Million	-21,767 Reduced 75.8%	6,949 $1.71 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $4.01 Million - $4.46 Million	16,473 Added 134.55%	28,716 $7.64 Million
Q4 2021 Feb 14, 2022	SELL	$230.08 - $250.94 $2.91 Million - $3.17 Million	-12,635 Reduced 50.79%	12,243 $3.08 Million
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $463,578 - $510,888	-1,992 Reduced 7.41%	24,878 $6.12 Million
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $185,887 - $203,409	-799 Reduced 2.89%	26,870 $6.54 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $748,026 - $827,924	3,223 Added 13.18%	27,669 $6.73 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $1.7 Million - $1.88 Million	7,657 Added 45.61%	24,446 $6.12 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $3.62 Million - $4.65 Million	16,789 New	16,789 $3.91 Million
Q1 2019 May 15, 2019	SELL	$206.05 - $248.17 $986,773 - $1.19 Million	-4,789 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $644,899 - $812,479	3,150 Added 192.19%	4,789 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $9.34 Million - $10.3 Million	-40,078 Reduced 96.07%	1,639 $428,000
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $8.68 Million - $9.76 Million	41,717 New	41,717 $9.99 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.